Sommario
Come prendere la mesalazina?
La mesalazina può essere somministrata per via orale (tramite l’assunzione di compresse o capsule, gastroresistenti o meno e/o a rilascio modificato) e per via rettale (usando gel, schiume o sospensioni rettali, granulato per sospensione rettale o supposte).
Cos’è il Pentacol?
Pentacol è un farmaco a base del principio attivo Mesalazina , appartenente alla categoria degli Antinfiammatori e nello specifico Acido aminosalicilico ed analoghi. E’ commercializzato in Italia dall’azienda Sofar S.p.A. . Pentacol può essere prescritto con Ricetta RR – medicinali soggetti a prescrizione medica.
Come prendere asacol compresse?
Le compresse vanno deglutite intere, senza frazionarle né masticarle, preferibilmente con un bicchiere d’acqua e lontano dai pasti. La durata del trattamento per le fasi attive è mediamente di 4-6 settimane e può variare, a giudizio del Medico, secondo le condizioni del paziente e l’evoluzione della malattia.
What is the composition of pentasa?
PENTASA is an ethylcellulose-coated, extended-release formulation of mesalamine designed to release therapeutic quantities of mesalamine throughout the gastrointestinal tract. Based on urinary excretion data, 20% to 30% of the mesalamine in PENTASA is absorbed.
How many capsules are in a pentasa 500mg?
PENTASA extended-release 500-mg capsules are supplied in bottles of 120 capsules (NDC 54092-191-12). Each blue capsule contains 500 mg of mesalamine in extended-release beads. PENTASA extended-release capsules are identified with a pentagonal starburst logo and S429 500 mg on the capsules.
What is the difference between 2-G and 4-G pentasa?
The 4-g dose of PENTASA induced remission as assessed by endoscopic and symptomatic endpoints. In some patients, the 2-g dose of PENTASA was observed to improve efficacy parameters measured. However, the 2-g dose gave inconsistent results in primary efficacy parameters across the two adequate and well-controlled trials.
What is the drug pentasa used to treat?
PENTASA is indicated for the induction of remission and for the treatment of adult patients with mildly to moderately active ulcerative colitis. PENTASA is contraindicated in patients with known or suspected hypersensitivity to salicylates, aminosalicylates, or any components of this medication.